University of California San Francisco
Give to UCSF
Scientists made universal stem-cell-derived dendritic "immune teacher" cells that can be coated with a patient’s tumor proteins, creating a cancer vaccine that activated tumor-killing T cells in laboratory studies, patient samples, and mouse models.
The number of low and intermediate-risk prostate cancer patients undergoing active surveillance in place of aggressive treatment has tripled to quadrupled over the last 20 years.
MRIs are among the most accurate imaging tests used to diagnose brain tumors, and MRI-based monitoring of tumors guides critical treatment decisions. The clinical standard for measuring tumors
UCSF Health’s Adam Blaisdell, MD, PhD, has been selected as an IGNITE fellow by the Cancer Research Institute (CRI), a New York-based nonprofit that funds and promotes cancer immunotherapy research.
Breast cancer is known to disproportionately affect Asian American women who never smoked. Now, a new study documents a new breast cancer trend.
UCSF researchers are using tiny "mini-organs" to model disease, personalize treatment, and understand human development. They are also addressing the limitations holding the field back: giving organoids a vascular system and making organoids reproducible.
UCSF’s Dr. Pamela Ling explains why the FDA’s Zyn ruling risks a new generation of nicotine addiction, despite being marketed as a safer cigarette alternative.
Roarke Kamber earns funding for research that directs the immune system’s “big eaters,” macrophages, to eat tumor cells.
See three examples of how food and lifestyle choices — from plant-based eating to ketogenic diets — help slow cancer progression, improve survival, and make some existing cancer treatments more effective.
A UCSF team developed an automated system for seeing and understanding persister cells, the tumor cells that survive cancer treatment and regrow tumors.
Rushika M. Perera, the Deborah Cowan Professor and vice chair of the Department of Anatomy, and chief scientific officer of UCSF’s Pancreas Center, shared her insights on pancreatic cancer on April 16 when she presented the 2026 Byers Award Lecture in Basic Science.
UCSF scientists found a precise way to turn on cancer-fighting immune cells inside the body. This more potent form of CAR-T has the potential to treat many more cancers.
A UCSF team discovers that a notorious cancer-causing enzyme called SRC exists on the outside of many tumors - so they're turning it into a cancer drug.
UCSF received $824 million from the National Institutes of Health (NIH) in 2025 to drive the discovery, translational, and clinical science that leads to new treatments for disease and advances U.S. leadership in health and science.
This Q&A with George Sawaya, MD, explores new cervical cancer screening guidelines issued in January 2026, which recommend at-home HPV testing. A recent study found most U.S. women ages 21–49 are open to home HPV screening—an approach that could reduce barriers like embarrassment and anxiety around pelvic exams while improving early cervical cancer detection.
At the new Weill Cancer Hub West, Kole Roybal, PhD, is reimagining how immune cells fight solid tumors.
Johannes R. Kratz, MD, has been named as the inaugural chief of UCSF’s Division of Thoracic Surgery, one of the leading academic robotic thoracic surgery programs in the western U.S. He brings a track
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient’s own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation
Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of
A study finds personalized breast cancer screening based on risk reduces advanced cancers and ensures safe, tailored mammogram frequency.
A study shows that young people who use tanning beds have more skin mutations including cells known to lead to skin cancer.
Differentiated thyroid cancer is the most frequently diagnosed thyroid cancer in the U.S. Recently, the American Thyroid Association (ATA) released new practice guidelines for Differentiated thyroid
The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny “pocket” on a protein that signals the cells to grow and divide was discovered, leading to the world's first FDA-approved drugs that can now target and destroy these cancer cells.
Senescent fibroblasts are aging cells in connective tissue that no longer divide and protect against tumor development. Yet, these same cells can promote cancer growth in a laboratory setting.Until
Lee May, diagnosed with aggressive multiple myeloma at 59, defied odds with cutting-edge treatments at UCSF Health, including CAR-T therapy and NIH-funded innovations. Now 74 and in remission, May credits advanced research for his survival. UCSF leads the way in transforming blood cancer care.
Neurologist Dr. Ptacek explains how "falling back" disrupts the 24-hour circadian clock, affecting mood and performance, with mitigation tips.
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to